These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10882449)

  • 21. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP-2 and MMP-9 by synovial cells: a possible cause of joint damage after intra-articular hemorrhage.
    Tajima T; Yoshida E; Yamashita A; Ohmura S; Tomitaka Y; Sugiki M; Asada Y; Maruyama M
    J Orthop Res; 2005 Jul; 23(4):891-8. PubMed ID: 16023005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity.
    Loeuille D; Chary-Valckenaere I; Champigneulle J; Rat AC; Toussaint F; Pinzano-Watrin A; Goebel JC; Mainard D; Blum A; Pourel J; Netter P; Gillet P
    Arthritis Rheum; 2005 Nov; 52(11):3492-501. PubMed ID: 16255041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
    Tetlow LC; Adlam DJ; Woolley DE
    Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of a novel matrix protein with the degree of cartilage degradation.
    Schmidt-Rohlfing B; Schneider U; Thomsen M; Bosserhoff AK
    Rheumatol Int; 2002 Aug; 22(4):165-9. PubMed ID: 12172957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host metalloproteinases in Lyme arthritis.
    Hu LT; Eskildsen MA; Masgala C; Steere AC; Arner EC; Pratta MA; Grodzinsky AJ; Loening A; Perides G
    Arthritis Rheum; 2001 Jun; 44(6):1401-10. PubMed ID: 11407701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities.
    Marini S; Fasciglione GF; Monteleone G; Maiotti M; Tarantino U; Coletta M
    Clin Biochem; 2003 Jun; 36(4):295-304. PubMed ID: 12810159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degenerated human articular cartilage at autopsy represents preclinical osteoarthritic cartilage: comparison with clinically defined osteoarthritic cartilage.
    van Valburg AA; Wenting MJ; Beekman B; Te Koppele JM; Lafeber FP; Bijlsma JW
    J Rheumatol; 1997 Feb; 24(2):358-64. PubMed ID: 9034997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR; Okouneff S; Ionescu M; Poole AR
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
    Guo WS; Ma L; Li ZR
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of synovial fluid and articular cartilage VIP in human osteoarthritic knee: a new indicator of disease severity?
    Jiang W; Gao SG; Chen XG; Xu XC; Xu M; Luo W; Tu M; Zhang FJ; Zeng C; Lei GH
    Clin Biochem; 2012 Dec; 45(18):1607-12. PubMed ID: 22959974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of joint fluid analysis for determining cartilage damage in osteonecrosis of the knee.
    Saito T; Takeuchi R; Mitsuhashi S; Uesugi M; Yoshida T; Koshino T
    Arthritis Rheum; 2002 Jul; 46(7):1813-9. PubMed ID: 12124865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes.
    Henrotin YE; Deberg MA; Crielaard JM; Piccardi N; Msika P; Sanchez C
    J Rheumatol; 2006 Aug; 33(8):1668-78. PubMed ID: 16832844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice.
    Sahebjam S; Khokha R; Mort JS
    Arthritis Rheum; 2007 Mar; 56(3):905-9. PubMed ID: 17328064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
    Jain A; Nanchahal J; Troeberg L; Green P; Brennan F
    Arthritis Rheum; 2001 Aug; 44(8):1754-60. PubMed ID: 11508425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model.
    Salminen HJ; Säämänen AM; Vankemmelbeke MN; Auho PK; Perälä MP; Vuorio EI
    Ann Rheum Dis; 2002 Jul; 61(7):591-7. PubMed ID: 12079898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.